Kyntra Bio (NASDAQ: KYNB) investors back board, pay and PwC auditor
Rhea-AI Filing Summary
Kyntra Bio, Inc. reported results from its 2026 annual stockholder meeting held on June 12, 2026. Stockholders elected Class III director Michael Kauffman, M.D., Ph.D., to serve until the 2029 annual meeting, with 1,239,169 votes for, no votes against, 51,081 withheld, and 1,444,428 broker non-votes.
Stockholders also approved, on an advisory basis, the compensation of the company’s named executive officers, with 1,242,005 votes for, 23,606 against, 24,639 abstentions, and 1,444,428 broker non-votes. In addition, they ratified the Audit Committee’s selection of PricewaterhouseCoopers LLP as independent registered public accounting firm for the year ending December 31, 2026, with 2,712,825 votes for, 14,392 against, and 7,461 abstentions.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 5.07 — Submission of Matters to a Vote of Security Holders
1 item
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Key Figures
Director election votes for: 1,239,169 shares
Director election withheld: 51,081 shares
Broker non-votes (Proposals 1 and 2): 1,444,428 shares
+4 more
7 metrics
Director election votes for
1,239,169 shares
Votes for Class III director Michael Kauffman, M.D., Ph.D.
Director election withheld
51,081 shares
Withheld votes for Class III director election
Broker non-votes (Proposals 1 and 2)
1,444,428 shares
Broker non-votes on director election and say-on-pay
Say-on-pay votes for
1,242,005 shares
Advisory approval of named executive officer compensation
Say-on-pay votes against
23,606 shares
Votes against executive compensation advisory proposal
Auditor ratification votes for
2,712,825 shares
Ratification of PricewaterhouseCoopers LLP for 2026
Auditor ratification votes against
14,392 shares
Votes against ratifying PricewaterhouseCoopers LLP
Key Terms
broker non-votes, named executive officers, independent registered public accounting firm, Emerging growth company
4 terms
broker non-votes financial
"1,239,169 shares of Common Stock voted for, 0 against, 51,081 withheld, and 1,444,428 broker non-votes."
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
named executive officers financial
"The stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in the 2026 definitive proxy statement"
Named executive officers are the senior company leaders whose names, roles and compensation are singled out in required regulatory filings; this typically includes the chief executive, chief financial officer and the next highest‑paid senior officers. Investors treat this list like a team roster — it shows who makes key decisions, how they are paid and whether incentives align with shareholder interests, so changes or pay patterns can signal governance quality, risk or strategic shifts.
independent registered public accounting firm financial
"the selection of PricewaterhouseCoopers LLP ... as the independent registered public accounting firm of the Company for the year ending December 31, 2026"
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
Emerging growth company regulatory
"Emerging growth company Item 5.07 Submission of Matters to a Vote of Security Holders."
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
Which audit firm will serve Kyntra Bio (KYNB) for 2026 and how was it ratified?
PricewaterhouseCoopers LLP was ratified as Kyntra Bio’s independent registered public accounting firm for the year ending December 31, 2026. Shareholders cast 2,712,825 votes for, 14,392 against, and 7,461 abstentions, signaling broad support for continuing the existing audit relationship.
What were the broker non-vote totals at Kyntra Bio’s 2026 annual meeting?
Broker non-votes totaled 1,444,428 shares on both the director election and the advisory vote on executive compensation. Broker non-votes typically arise when beneficial owners do not provide voting instructions on non-routine proposals presented at the meeting.